Skip Navigation

A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study ICON study number: 0798/0661

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT02960022

Study #:
STUDY00150578

Start Date:
Nov 30, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02960022

View Complete Trial Details & Eligibility at ClinicalTrials.gov